Your browser doesn't support javascript.
loading
Design and Biochemical Characterization of Peptidic Inhibitors of the Myb/p300 Interaction.
Jones, Matthew; Grosche, Philipp; Floersheimer, Andreas; André, Jérome; Gattlen, Raphael; Oser, Dieter; Tinchant, Juliette; Wille, Roman; Chie-Leon, Barbara; Gerspacher, Marc; Ertl, Peter; Ostermann, Nils; Altmann, Eva; Manchado, Eusebio; Vorherr, Thomas; Chène, Patrick.
Afiliación
  • Jones M; Disease Area Oncology, Novartis Institutes for Biomedical Research, Basel CH-4002, Switzerland.
  • Grosche P; Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Basel CH-4002, Switzerland.
  • Floersheimer A; Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Basel CH-4002, Switzerland.
  • André J; Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Basel CH-4002, Switzerland.
  • Gattlen R; Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Basel CH-4002, Switzerland.
  • Oser D; Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Basel CH-4002, Switzerland.
  • Tinchant J; Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Basel CH-4002, Switzerland.
  • Wille R; Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Basel CH-4002, Switzerland.
  • Chie-Leon B; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Emeryville, California 94608, United States.
  • Gerspacher M; Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Basel CH-4002, Switzerland.
  • Ertl P; Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Basel CH-4002, Switzerland.
  • Ostermann N; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Emeryville, California 94608, United States.
  • Altmann E; Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Basel CH-4002, Switzerland.
  • Manchado E; Disease Area Oncology, Novartis Institutes for Biomedical Research, Basel CH-4002, Switzerland.
  • Vorherr T; Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Basel CH-4002, Switzerland.
  • Chène P; Disease Area Oncology, Novartis Institutes for Biomedical Research, Basel CH-4002, Switzerland.
Biochemistry ; 62(7): 1321-1329, 2023 04 04.
Article en En | MEDLINE | ID: mdl-36883372
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Péptidos / Proteínas Proto-Oncogénicas c-myb / Proteína p300 Asociada a E1A Tipo de estudio: Prognostic_studies Idioma: En Revista: Biochemistry Año: 2023 Tipo del documento: Article País de afiliación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Péptidos / Proteínas Proto-Oncogénicas c-myb / Proteína p300 Asociada a E1A Tipo de estudio: Prognostic_studies Idioma: En Revista: Biochemistry Año: 2023 Tipo del documento: Article País de afiliación: Suiza